Goldman Sachs Group Inc. Sells 112,235 Shares of Stevanato Group S.p.A. (NYSE:STVN)

Goldman Sachs Group Inc. cut its holdings in Stevanato Group S.p.A. (NYSE:STVN) by 15.8% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 597,606 shares of the company’s stock after selling 112,235 shares during the quarter. Goldman Sachs Group Inc.’s holdings in Stevanato Group were worth $16,309,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. SRS Capital Advisors Inc. lifted its position in shares of Stevanato Group by 327.1% during the 4th quarter. SRS Capital Advisors Inc. now owns 1,593 shares of the company’s stock valued at $43,000 after acquiring an additional 1,220 shares during the period. PNC Financial Services Group Inc. bought a new position in shares of Stevanato Group during the 3rd quarter worth about $60,000. Fifth Third Bancorp grew its stake in shares of Stevanato Group by 62.1% in the 4th quarter. Fifth Third Bancorp now owns 4,009 shares of the company’s stock valued at $109,000 after buying an additional 1,536 shares during the period. First Horizon Advisors Inc. increased its position in Stevanato Group by 14.1% in the 4th quarter. First Horizon Advisors Inc. now owns 5,311 shares of the company’s stock valued at $145,000 after buying an additional 657 shares in the last quarter. Finally, Jag Capital Management LLC acquired a new position in Stevanato Group during the 3rd quarter worth approximately $209,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Morgan Stanley restated an “equal weight” rating and set a $30.00 price objective on shares of Stevanato Group in a report on Monday, April 22nd. Stephens restated an “overweight” rating and set a $38.00 price target on shares of Stevanato Group in a research note on Monday, March 25th. Finally, BNP Paribas started coverage on shares of Stevanato Group in a research note on Monday, April 22nd. They issued an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, Stevanato Group presently has an average rating of “Moderate Buy” and an average target price of €34.17 ($36.74).

Stevanato Group Price Performance

STVN opened at €18.73 ($20.14) on Friday. Stevanato Group S.p.A. has a 1 year low of €16.56 ($17.81) and a 1 year high of €36.30 ($39.03). The company has a quick ratio of 1.35, a current ratio of 1.92 and a debt-to-equity ratio of 0.21. The firm’s fifty day moving average price is €21.45 and its two-hundred day moving average price is €26.92.

Stevanato Group (NYSE:STVN) last released its quarterly earnings results on Thursday, May 9th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing the consensus estimate of €0.12 ($0.13) by (€0.03) (($0.03)). The firm had revenue of €256.24 million for the quarter, compared to analysts’ expectations of €261.28 million. Stevanato Group had a return on equity of 12.61% and a net margin of 12.57%. On average, equities analysts anticipate that Stevanato Group S.p.A. will post 0.54 EPS for the current year.

Stevanato Group Dividend Announcement

The firm also recently disclosed an annual dividend, which will be paid on Monday, July 15th. Shareholders of record on Tuesday, June 4th will be paid a $0.053 dividend. The ex-dividend date of this dividend is Tuesday, June 4th. This represents a yield of 0.29%.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.